SSII stock news · SS Innovations International
Get alerts for SSII
Follow SS Innovations International (SSII) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SSIIThe CEO of SS Innovations shared plans for growth after completing over 15,000 surgeries with its robotic system.
Good for SSIISS Innovations said first-half 2026 sales rose about 66% to about $25 million, and its robot system passed 15,000 procedures. This points to a stronger business outlook.
The CEO of SS Innovations shared plans for growth and announced finishing over 15,000 surgeries with its robot system.
Good for SSIISS Innovations reported first-half 2026 sales of about $25 million, up about 66% from a year earlier. Sales growth and procedure use point to stronger business prospects, though expansion plans remain unfinished.
SS Innovations International, Inc. says it answered the FDA's questions about its surgical robot application.
NeutralSS Innovations sent the FDA its requested information about the Mantra surgical robot. No FDA decision is reported, so the filing does not change the company's outlook.
SS Innovations International, Inc. shares updates on its progress and achievements.
NeutralSS Innovations filed an 8-K that attaches a press release about progress; it supplies no financial numbers, so the filing leaves the company's picture unchanged.
SS Innovations International, Inc. discloses operational results and financial status (SSII).
NeutralSS Innovations International, Inc. has filed a Form 8-K detailing its results of operations and financial condition, which is critical for investors to assess the company's performance and future outlook. This new information could lead to immediate trading activity as investors react to the disclosed financial metrics.